OBJECTIVE: TNF system (TNF and its soluble receptors sTNFR1 and 2) has been investigated as a potential molecular target in bipolar disorder. The aim of the study was to compare plasma levels of these receptors in unmedicated bipolar depressed patients compared with healthy controls, and to evaluate the effects of a 6-week lithium treatment on sTNFR1 and sTNFR2 levels. METHODS: The study enrolled 29 patients with unmedicated bipolar disorder in a major depressive episode and 27 matched controls. Patients had blood collected at baseline and after 6 weeks of lithium treatment. The concentration of sTNFRs was measured by ELISA. RESULTS: sTNFR1 and sTNFR2 levels were significantly increased in bipolar depression in comparison with healthy subjects. Lithium treatment did not significantly change sTNFR1 and sTNFR2 levels from baseline to endpoint. There was no correlation between improvement in depressive symptoms and the change in sTNFR1 or sTNFR1 levels. CONCLUSION: These results reinforce the involvement of an activated immune response system in the pathophysiology of bipolar disorder, with no impact of lithium treatment on the related biomarkers.
OBJECTIVE:TNF system (TNF and its soluble receptors sTNFR1 and 2) has been investigated as a potential molecular target in bipolar disorder. The aim of the study was to compare plasma levels of these receptors in unmedicated bipolar depressedpatients compared with healthy controls, and to evaluate the effects of a 6-week lithium treatment on sTNFR1 and sTNFR2 levels. METHODS: The study enrolled 29 patients with unmedicated bipolar disorder in a major depressive episode and 27 matched controls. Patients had blood collected at baseline and after 6 weeks of lithium treatment. The concentration of sTNFRs was measured by ELISA. RESULTS: sTNFR1 and sTNFR2 levels were significantly increased in bipolar depression in comparison with healthy subjects. Lithium treatment did not significantly change sTNFR1 and sTNFR2 levels from baseline to endpoint. There was no correlation between improvement in depressive symptoms and the change in sTNFR1 or sTNFR1 levels. CONCLUSION: These results reinforce the involvement of an activated immune response system in the pathophysiology of bipolar disorder, with no impact of lithium treatment on the related biomarkers.
Authors: Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate Journal: World J Biol Psychiatry Date: 2013-09-02 Impact factor: 4.132
Authors: Flávio Kapczinski; Felipe Dal-Pizzol; Antonio Lucio Teixeira; Pedro V S Magalhaes; Márcia Kauer-Sant'Anna; Fábio Klamt; José Claudio F Moreira; Mateus Augusto de Bittencourt Pasquali; Gabriel Rodrigo Fries; João Quevedo; Clarissa Severino Gama; Robert Post Journal: J Psychiatr Res Date: 2010-06-11 Impact factor: 4.791
Authors: Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; Serge Beaulieu; Martin Alda; Claire O'Donovan; Glenda Macqueen; Roger S McIntyre; Verinder Sharma; Arun Ravindran; L Trevor Young; Roumen Milev; David J Bond; Benicio N Frey; Benjamin I Goldstein; Beny Lafer; Boris Birmaher; Kyooseob Ha; Willem A Nolen; Michael Berk Journal: Bipolar Disord Date: 2012-12-12 Impact factor: 6.744
Authors: Antonio Lucio Teixeira; Izabela Guimarães Barbosa; Rodrigo Machado-Vieira; Lucas Bortolotto Rizzo; Andrea Wieck; Moisés E Bauer Journal: Expert Opin Med Diagn Date: 2012-12-16
Authors: Minkyung Park; Laura E Newman; Philip W Gold; David A Luckenbaugh; Peixiong Yuan; Rodrigo Machado-Vieira; Carlos A Zarate Journal: J Psychiatr Res Date: 2016-09-30 Impact factor: 4.791
Authors: C E Millett; J Harder; J J Locascio; M Shanahan; G Santone; R N Fichorova; A Corrigan; C Baecher-Allan; K E Burdick Journal: Brain Behav Immun Date: 2020-04-06 Impact factor: 7.217
Authors: Nazakat Hussain Memon; Mei Fan; Jia Lin; Yan Jun Si; Mi Su; Qi Wei Guo; Ding Zhi Fang Journal: Int J Environ Res Public Health Date: 2018-05-25 Impact factor: 3.390
Authors: Peter Memiah; Lillian Nkinda; Mtebe Majigo; Felix Humwa; Zelalaem Haile; Kennedy Muthoka; Aisha Zuheri; Anne Kamau; Lucy Ochola; Gabriel Buluku Journal: BMC Public Health Date: 2021-06-10 Impact factor: 3.295
Authors: Magdalena Sowa-Kućma; Krzysztof Styczeń; Marcin Siwek; Paulina Misztak; Rafał J Nowak; Dominika Dudek; Janusz K Rybakowski; Gabriel Nowak; Michael Maes Journal: Neurotox Res Date: 2017-11-04 Impact factor: 3.911
Authors: Rodrigo B Mansur; Francheska Delgado-Peraza; Mehala Subramaniapillai; Yena Lee; Michelle Iacobucci; Nelson Rodrigues; Joshua D Rosenblat; Elisa Brietzke; Victoria E Cosgrove; Nicole E Kramer; Trisha Suppes; Charles L Raison; Sahil Chawla; Carlos Nogueras-Ortiz; Roger S McIntyre; Dimitrios Kapogiannis Journal: Cells Date: 2020-04-06 Impact factor: 6.600